Comparing Breast Magnetic Resonance Imaging (MRI) and Contrast-enhanced Mammography (CEM) - Trial NCT06008301
Access comprehensive clinical trial information for NCT06008301 through Pure Global AI's free database. This phase not specified trial is sponsored by Boston Medical Center and is currently Not yet recruiting. The study focuses on Breast Cancer Female. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Boston Medical Center
Timeline & Enrollment
N/A
Dec 01, 2023
Sep 01, 2025
Primary Outcome
Institutional financial costs,Patient financial costs,Time from diagnosis to imaging modality (CEM or MRI),Time from diagnosis to first treatment,Number of patient visits generated from the imaging modality,Psychologic costs to patients
Summary
The investigators will study the financial, time, and psychologic benefit of Contrast
 Enhanced Mammography (CEM) compared with Magnetic Resonance Imaging (MRI) for breast cancer
 evaluation and ultimately encourage practices and referring providers to use it more
 routinely in practice.
 
 Specific research objectives are to:
 
 - determine financial costs of performing a CEM to breast MRI
 
 - compare time costs involved with CEM to breast MRI
 
 - compare psychologic costs involved with CEM to breast MRI.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06008301
Non-Device Trial